Table 1 Disease-related radiotherapy in breast cancer patients with distant metastatic disease
From: Radiotherapy in patients with distant metastatic breast cancer
Variable | n (%) |
|---|---|
Entire cohort of the BBCD | 1459 |
Patients with distant metastases (DM) | 369 (25.3) |
PMD: DM at initial diagnosis | 92 (6.3) |
SMD: DM developed during the course of the illness | 277 (19.0) |
Patients with complete information about disease and therapy course. | 363 |
Last follow-up: alive1 | 23 (6.3) |
Study cohort: patients who died, i.e. patients with completed disease and therapy courses | 340 (93.7) |
Study cohort | 340 |
A. Breast cancer-related radiotherapy | 165 (48.5) |
B. No radiotherapy | 175 (51.5) |
Breast cancer-related radiotherapy | |
Number of patients | 165 |
Number of series | 255 |
median/mean (range) | 1/1.6 (1-5) |
Number of planning target volumes | 337 |
median/mean (range) | 2/2.0 (1-8) |
Metastatic sites and radiation volumes | 337 |
Breast and locoregional lymph nodes | 35 (10.4) |
- primary tumor region after surgery (PMD) | 8 (2.4) |
- primary breast tumor without surgery (PMD) | 3 (0.9) |
- recurrence at the chest wall, no surgery | 6 (1.8) |
- chest wall after surgery for local recurrence | 1 (0.3) |
- recurrence at locoregional lymph nodes | 17 (5.0) |
Bone | 217 (64.4) |
- vertebrae and osseous pelvis | 137 (40.7) |
- other sites | 80 (23.7) |
Brain | 57 (16.9) |
Other locations | 28 (8.3) |
- skin/soft tissue | 13 (3.8) |
- mediastinum | 6 (1.8) |
- eye | 3 (0.9) |
- lung | 3 (0.9) |
- cervical lymph nodes | 2 (0.6) |
- liver | 1 (0.3) |